Total Liabilities (Quarterly)

Total Liabilities: The total value of all possible claims against the corporation.

CorMedix Inc (CRMD) had Total Liabilities of $420.83M for the most recently reported fiscal quarter, ending 2025-12-31.

Quarterly Annual

Figures for fiscal quarter ending 2025-12-31

Income Statement Financials
Revenue	$128.62M
Net Income	$14.02M
Cost of Goods Sold	$21.31M
Gross Profit	$107.31M
Operating Expenses	$69.49M
Operating Income	$59.13M
Non-Operating Income/Expense	$-2.68M
Pre-Tax Income	$56.45M
Normalized Pre-Tax Income	$56.45M
Income after Taxes	$14.02M
Income from Continuous Operations	$14.02M
Consolidated Net Income/Loss	$14.02M
Normalized Income after Taxes	$14.02M
EBIT	$59.13M
EBITDA	$70.21M
Weighted-Average Shares Outstanding (Basic)	72.03M
Weighted-Average Shares Outstanding (Diluted)	80.31M
Earnings per Share (EPS) (Basic)	$0.22
Earnings per Share (EPS) (Diluted)	$0.20
Balance Sheet Financials
Current Assets	$367.05M
Property, Plant, and Equipment	$5.96M
Long-Term Assets	$459.09M
Total Assets	$826.14M
Current Liabilities	$174.27M
Long-Term Debt	$145.21M
Long-Term Liabilities	$246.57M
Total Liabilities	$420.83M
Common Equity	$405.31M
Tangible Shareholders Equity	$-3.77M
Shareholders Equity	$405.31M
Common Shares Outstanding	79.26M
Cash Flow Statement Financials
Cash Flow from Operating Activities	$175.05M
Cash Flow from Investing Activities	$-308.43M
Cash Flow from Financial Activities	$238.45M
Beginning Cash	$40.76M
End Cash	$145.82M
Increase/Decrease in Cash	$105.07M
Stock-Based Compensation	$13.83M
Common Stock Dividends Paid	--
Preferred Stock Dividends Paid	--
Fundamental Metrics & Ratios
Current Ratio	2.11
Non-Performing Assets / Total Loans	--
Loan Loss Reserves / Non-Performing Loans	--
Debt to Capital Ratio	0.26
Debt to Equity Ratio	0.36
Gross Margin	83.43%
Operating Margin	45.97%
EBIT Margin	45.97%
EBITDA Margin	--
Pre-Tax Profit Margin	43.89%
Profit Margin	10.90%
Free Cash Flow	$172.79M
Loss Ratio	--
Expense Ratio	--
Combined Ratio	--
Asset Turnover	0.16
Inventory Turnover	0.72
Receiveable Turnover	0.75
Days Sales in Receivables	119.82
Return on Equity	3.46%
Return on Tangible Equity	-372.19%
Return on Assets	1.70%
Return on Investments	2.55%
Book Value Per Share	$5.11
Free Cash Flow per Share	$2.15
Operating Cash Flow per Share	$2.18

Data from Zacks Investment Research, Inc.